Correlation Between UPS CDR and NervGen Pharma

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both UPS CDR and NervGen Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining UPS CDR and NervGen Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between UPS CDR and NervGen Pharma Corp, you can compare the effects of market volatilities on UPS CDR and NervGen Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in UPS CDR with a short position of NervGen Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of UPS CDR and NervGen Pharma.

Diversification Opportunities for UPS CDR and NervGen Pharma

0.08
  Correlation Coefficient

Significant diversification

The 3 months correlation between UPS and NervGen is 0.08. Overlapping area represents the amount of risk that can be diversified away by holding UPS CDR and NervGen Pharma Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on NervGen Pharma Corp and UPS CDR is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on UPS CDR are associated (or correlated) with NervGen Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of NervGen Pharma Corp has no effect on the direction of UPS CDR i.e., UPS CDR and NervGen Pharma go up and down completely randomly.

Pair Corralation between UPS CDR and NervGen Pharma

Assuming the 90 days trading horizon UPS CDR is expected to generate 0.99 times more return on investment than NervGen Pharma. However, UPS CDR is 1.01 times less risky than NervGen Pharma. It trades about -0.04 of its potential returns per unit of risk. NervGen Pharma Corp is currently generating about -0.05 per unit of risk. If you would invest  1,622  in UPS CDR on December 21, 2024 and sell it today you would lose (105.00) from holding UPS CDR or give up 6.47% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

UPS CDR  vs.  NervGen Pharma Corp

 Performance 
       Timeline  
UPS CDR 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days UPS CDR has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy basic indicators, UPS CDR is not utilizing all of its potentials. The current stock price disarray, may contribute to short-term losses for the investors.
NervGen Pharma Corp 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days NervGen Pharma Corp has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest fragile performance, the Stock's technical and fundamental indicators remain stable and the latest fuss on Wall Street may also be a sign of long-term gains for the venture sophisticated investors.

UPS CDR and NervGen Pharma Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with UPS CDR and NervGen Pharma

The main advantage of trading using opposite UPS CDR and NervGen Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if UPS CDR position performs unexpectedly, NervGen Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in NervGen Pharma will offset losses from the drop in NervGen Pharma's long position.
The idea behind UPS CDR and NervGen Pharma Corp pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Watchlist Optimization module to optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm.

Other Complementary Tools

Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets